Multiplexed High Content Hepatotoxicity Assays using iPSC-Derived Hepatocytes
18 Sep 2012

Human hepatocytes derived from stem cells can greatly accelerate the development of new chemical entities and improve drug safety by offering more clinically relevant cell-based models than those presently available. Human induced pluripotent stem cell (iPSC) derived hepatocytes express appropriate hepatocyte markers and demonstrate intrinsic hepatocyte functions similar to primary cells. We demonstrate several models for assessing general and specific hepatotoxicity that are well-suited for automated screening environments.

Molecular Devices®



Show    per page
1 of 9 Page     1 2 3  ... Next 
Validation of the TruSight One Sequencing Panel for Clinical Research16 Oct 2014Read
Ion Mobility Derived Collision Cross Sections to Support Metabolomics and Lipidomics15 Oct 2014Read
Non-targeted and Targeted Analysis of Anionic Metabolites Using Ion Chromatography and High Resolution Accurate Mass Spectrometry1 Oct 2014Read
A new approach to improving early characterization of therapeutic formulations - Viscosizer 2005 Sep 2014Read
An introduction to capillary rheometry - Evaluating material properties under process relevant conditions5 Sep 2014Read
Speed your way though your protein formulation screening by automating your measurements5 Sep 2014Read
Novel analytical technologies for product deformulation - Part 25 Sep 2014Read
Water treatment - Optimize coagulant dosing using zeta potential5 Sep 2014Read
Applications of rheology in the waxes, creams and emulsions arena5 Sep 2014Read
Avoiding Bottlenecks When Validating Your Laboratory Instrument and Information Systems20 Aug 2014Read